Max Healthcare Institute Ltd

Max Healthcare Institute Ltd

817.00
INR
-2.90
(-0.35%)
14.91EPS
75.33P/E
1.10TMarket Cap
Oct 30Next Earn
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
- -
23.03
26.35
31.36
30.63
22.79
28.76
40.14
46.27
54.65
71.09
84.58
89.62
Basic EPS, GAAP
- -
-0.41
0.17
-0.55
-0.06
1.3
-1.59
6.25
11.38
10.89
11.07
14.83
14.99
Free Cash Flow per Basic Share
- -
-16.18
0.75
0.31
-0.49
-0.29
-0.01
1.93
9.78
3.46
5.08
1.53
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1.5
1.5
- -
Book Value per Share
9.54
12.47
12.23
11.43
10.65
28.23
58.37
64.79
76.31
86.51
96.5
110.43
- -
Tangible Book Value per Share
9.04
-1.96
-2.04
-2.6
-3.23
22.03
8.8
12.09
24.14
29.07
34.41
48.7
- -
Basic Weighted Avg Shares
905
546
546
546
546
453
863
967
970
972
972
972
972
Sales/Revenue/Turnover
- -
12,568
14,380
17,116
16,714
10,330
24,824
38,832
44,890
53,095
69,104
82,254
87,121
Operating Margin (%)
- -
1.17
4.03
1.43
3.36
5.1
11.63
20.44
23.28
24.19
22.81
22.82
21.17
Depreciation Expense
- -
912
1,076
974
1,026
456
1,741
2,211
2,322
2,450
3,594
4,465
4,741
Net Income, GAAP
- -
-226
91
-302
-30
590
-1,375
6,051
11,035
10,576
10,759
14,424
14,574
Effective Tax Rate (%)
- -
- -
- -
- -
102.28
- -
- -
18.11
- -
22.54
23.5
13.92
14.84
Profit Margin (%)
- -
-1.8
0.63
-1.76
-0.18
5.71
-5.54
15.58
24.58
19.92
15.57
17.54
16.73
Working Capital
1,081
-1,316
-338
-443
-6,927
19,054
3,475
2,430
8,975
4,575
-2,136
-2,421
- -
LT Debt
3,288
6,488
7,719
8,470
8,887
1,207
12,375
10,189
8,178
11,841
27,676
29,780
- -
Total Equity
8,630
11,282
11,060
10,340
9,632
25,532
56,387
62,825
74,096
84,081
93,809
107,466
- -
Return on Invested Capital (%)
- -
- -
- -
- -
-0.06
- -
- -
8.71
- -
10.87
10.02
11.62
- -
Return on Capital (%)
- -
- -
- -
- -
-0.4
- -
- -
9.44
- -
12.12
10.77
12.23
- -
Return on Common Equity (%)
- -
-2.27
0.81
-2.82
-0.3
3.36
-3.36
10.15
16.12
13.37
12.1
14.33
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
5,004
- -
LT Borrowings
- -
24,387
- -
LT Finance Leases
- -
5,393
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
973
973
973
Market Capitalization
1,016,641
936,448
1,099,036

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
19,448
- -
Cash, Cash Equivalents & STI
- -
6,684
- -
Accounts Receivable, Net
- -
9,698
- -
Inventories
- -
1,143
- -
Total Current Liabilities
- -
21,869
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
5,004
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
33.96%
13.79%
14.56%
Free Cash Flow
-3,377.73%
-6,641.15%
-69.85%
Net Income, GAAP
-348.22%
-85.17%
34.07%
Sales/Revenue/Turnover
27.27%
27.9%
19.03%
Total Cash Common Dividend
- -
- -
0.03%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
15,430
17,075
18,683
19,097
69,104
2026
20,276
21,355
20,675
21,429
82,254
2027
23,662
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2.43
2.9
2.46
3.28
11.07
2026
3.17
5.05
3.1
3.52
14.83
2027
3.32
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
1.5
2026
- -
- -
- -
- -
1.5
2027
- -
- -
- -
- -
- -

Company Description

CEO
Abhay Soi
Full Time Employees
31,127
Sector
Health services
Industry
Hospital/Nursing management
Address
Capital Cyberscape Gurugram HR India 122102
IPO Date
Aug 21, 2020
Business
Max Healthcare Institute Limited operates as one of India's leading private hospital chains, providing comprehensive multi-specialty healthcare services through a network of hospitals, diagnostic labs, and home care offerings. The company delivers advanced medical care across specialties including cardiac sciences, oncology, neurosciences, orthopaedics, renal sciences, minimal access metabolic and bariatric surgery, obstetrics and gynaecology, paediatrics, nephrology, general surgery, urology, eye care, dermatology, lung care, liver, heart, kidney, lung and bone marrow transplants; it also offers diagnostic services via Max Lab, home health and wellness solutions through Max@Home including nursing, house calls and medicine delivery, emergency and trauma care, telemedicine, international patient services, and preventive health plans. Founded in 2000 and headquartered in New Delhi with primary operations in North India including the National Capital Region, Mumbai, Lucknow and Nagpur, Max Healthcare manages 22 facilities exceeding 5,000 beds as of mid-2025, serving domestic and international patients through its owned hospitals, subsidiaries and strategic partnerships. Recent developments include the September 2024 acquisition of a controlling 64% stake in Jaypee Healthcare for an enterprise value of Rs 1,660 crore, adding hospitals in Noida, Bulandshahr and Anupshahr followed by the divestment of the latter two smaller facilities in 2025 for Rs 40 crore to focus on super-specialty expansions in larger cities; earlier moves encompassed the February 2024 purchase of Alexis Multi-Specialty Hospital in Nagpur for Rs 412 crore, the December 2023 acquisition of Sahara Hospital in Lucknow for Rs 940 crore, and the National Company Law Tribunal's November 2025 approval of a subsidiary merger involving Crosslay Remedies and Jaypee Healthcare with an effective date of October 2024.